Revelation Biosciences (REVB) Non-Current Deffered Revenue (2020 - 2024)
Revelation Biosciences' Non-Current Deffered Revenue was $1.38 million in Q2 2024, down 52.5% from $2.91 million a year earlier and down 52.5% from the prior quarter.
Powered by 
Analysis
Revelation Biosciences (REVB) Non-Current Deffered Revenue (2020 - 2024) Analysis & Trends
At the end of FY2023, Non-Current Deffered Revenue at Revelation Biosciences came in at $2.91 million, unchanged from FY2022.
- Non-Current Deffered Revenue shows a three-year compound annual growth rate of 0.0% (FY2020 to FY2023).
- In earlier years, Non-Current Deffered Revenue was $2.91 million in FY2022 (unchanged), $2.91 million in FY2021 (unchanged) and $2.91 million in FY2020.
- The Q2 2024 figure marks the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2020.
- Over the past five years, the year-over-year decline in Non-Current Deffered Revenue ranged from 0.0% (Q1 2024) to 52.5% (Q2 2024).
- Per Business Quant data, REVB's Non-Current Deffered Revenue in the three quarters before Q2 2024 was $2.91 million (Q1 2024), $2.91 million (Q4 2023) and $2.91 million (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Revelation Biosciences | 3.20 Mn | -45.82 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 2.91 Mn |
| Dec 31, 2023 | 2.91 Mn |
| Sep 30, 2023 | 2.91 Mn |
| Jun 30, 2023 | 2.91 Mn |
| Mar 31, 2023 | 2.91 Mn |
| Dec 31, 2022 | 2.91 Mn |
| Sep 30, 2022 | 2.91 Mn |
| Jun 30, 2022 | 2.91 Mn |
| Mar 31, 2022 | 2.91 Mn |
| Dec 31, 2021 | 2.91 Mn |
| Sep 30, 2021 | 2.91 Mn |
| Jun 30, 2021 | 2.91 Mn |
| Mar 31, 2021 | 2.91 Mn |
| Dec 31, 2020 | 2.91 Mn |
API Access
Revelation Biosciences Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();